The Bempu ApneBoot is a shoe that monitors, alerts, and treats for infant episodes of central apnea.
The ApneBoot is an apnea monitoring device for infants developed by Bempu Health. The device is in prototype stage and is currently undergoing clinical validation. ApneBoot is a shoe that monitors an infant for episodes of central apnea. When one is detected, the shoe vibrates the infant’s foot (stimulating the nervous system to restart breathing) to prevent apnea related damage. It sends out alarms (using both sound and light) to alert nurses and caretakers that an episode of central apnea is occurring. The ApenBoot can be used in homes, wards, neonatal intensive care units, and during medical transport.
Because the device is still in development, the retail price is unknown
Goal 3: Good health and well-being
Caretakers: Nurses and understaffed hospitals, mothers, ambulance operators
ApneBoot is currently a prototype and manufacturing has not yet begun.
Bempu Health’s first product, the TempWatch, is sold directly through the manufacturer. The ApneBoot is still in development.
LEDs, audio alarm w/dB level, etc.
temperature, oxygen saturation, HR, etc.
The ApneBoot monitors the pulse rate and oxygen saturation of the infant using an SpO2 sensor. If an episode of apnea is detected, the shoe vibrates, waking the infant and stimulating the nervous system to restart breathing. It also alerts caretakers if apnea is detected. The ApneBoot is designed with medical grade silicon so it is easy to strap on, easy to clean and disinfect, and is comfortable for the infant. It is also designed to fit babies of varying weight.
Provided by the manufacturer
This product is a prototype so the lifecycle is not yet known.
- Responds instantaneously
- Automatically stimulates the infants foot
- No training required
- Usable in clinic, home, and transport as well as during Kangaroo Mother Care
Clinical trials are currently being conducted by Bempu Health. Preliminary findings from a non-randomized study at Niloufer Hospital, Hyderabad found that 44% of apneas resolved within 15 seconds, likely attributed to the ApneBoot. 53% of apneas did not resolve in 15 seconds, most likely because they were not central apneas.
No known safety hazards are related to this product
This product is in clinical validation in 3 hospitals including Niloufer Hospital in India to evaluate the percentage of apneas resolved by the ApneBoot. It received a Saving Lives at Birth (SLAB) grant to run controlled clinical trials comparing the efficacy of the ApneBoot to other standards of care.
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.